From: Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance
Percentage malignant cells | Model I | Model II | Model III | Model IV | |
---|---|---|---|---|---|
MCC | 5% | 0.41 | 0.41 | 0.40 | 0.41 |
10% | 0.39 | 0.39 | 0.37 | 0.39 | |
15% | 0.40 | 0.40 | 0.36 | 0.40 | |
20% | 0.37 | 0.37 | 0.33 | 0.37 | |
25% | 0.36 | 0.36 | 0.32 | 0.36 | |
30% | 0.35 | 0.35 | 0.30 | 0.35 | |
35% | 0.31 | 0.31 | 0.28 | 0.31 | |
40% | 0.31 | 0.31 | 0.28 | 0.31 | |
Sensitivity | 5% | 0.62 | 0.62 | 0.79 | 0.62 |
10% | 0.66 | 0.66 | 0.82 | 0.66 | |
15% | 0.71 | 0.71 | 0.86 | 0.71 | |
20% | 0.73 | 0.73 | 0.85 | 0.73 | |
25% | 0.75 | 0.75 | 0.88 | 0.75 | |
30% | 0.79 | 0.79 | 0.90 | 0.79 | |
35% | 0.77 | 0.77 | 0.91 | 0.77 | |
40% | 0.80 | 0.80 | 0.96 | 0.80 | |
Specificity | 5% | 0.84 | 0.84 | 0.71 | 0.84 |
10% | 0.82 | 0.82 | 0.70 | 0.82 | |
15% | 0.82 | 0.82 | 0.69 | 0.82 | |
20% | 0.81 | 0.81 | 0.68 | 0.81 | |
25% | 0.80 | 0.80 | 0.67 | 0.80 | |
30% | 0.80 | 0.80 | 0.67 | 0.80 | |
35% | 0.79 | 0.79 | 0.66 | 0.79 | |
40% | 0.79 | 0.79 | 0.66 | 0.79 |